// App-Quantinova.ai

Tu1029 : Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon ?-2B for Advanced Hepatocellular Carcinoma

Researchers

Presenter

  • Kazuhiro Kasai

Principal Investigators

  • Kei Sawara

  • Kazuyuki Suzuki

Medical Centers

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Interferon

Drug/Treatment

  • Adrucil injection

  • Interferon

  • Sorafenib

  • PEG-IFN

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved